申请人:MEDICON PHARMACEUTICALS, INC.
公开号:US20190307780A1
公开(公告)日:2019-10-10
Compounds of the general formula
are disclosed with activity towards treating diseases related to inflammation, such as cancer, neurodegenerative and cardiovascular diseases. Pharmaceutical compositions and methods of use are also described.